4Stern N, Sturgess R. Endoscopic therapy in the man- agement of malignant biliary obstruction[J]. Eur J Surg Oncol, 2008,34 :313-317.
5Cipolletta L, Rotondano G, Marmo R, Bianco M A; I- talian Evidence-Based Gastroenterology Hepatology Club. Endoscopic palliation of malignant obstructive jaundice., an evidence-based review [J]. Dig Liver Dis, 2007,39 :375-388.
6Ballinger A B,McHugh M,Catnach S M,Alstead E M, Clark M L. Symptom relief and quality of life after stenting for malignant bile duct obstruction[J]. Gut, 1994,35:467-470.
7Kahaleh M,Tokar J, Conaway M R, Brock A, Le T, Adams R B, et al. Efficacy and complications of covered Wallstents in malignant distal biliary obstruction[J]. Gastrointest Endosc, 2005,61 : 528-533.
8Cho Y K,Kim J K,Kim M Y,Rhim H,Han J K. Sys- tematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies [J]. Hepatology, 2009,49 : 453-459.
9Mulier S, Ruers T, Jamart J, Michel L, Marchal G, Ni Y. Radiofrequency ablation versus resection for resect- able colorectal liver metastases., time for a randomized trial? An update[J]. Dig Surg, 2008,25 : 445-460.
10Khorsandi S E, Zacharoulis D, Vavra P, Navarra G, Kysela P, Habib N. The modern use of radiofrequency energy in surgery, endoscopy and interventional radiol- ogy[J]. Eur Surg, 2008,40 : 204-210.